MétaCan
Menu
Back to cohort

The development of a prediciton index for patients at high risk of severe chemotherapy induced nausea and vomiting

2005· article· en· W2589657590 on OpenAlexaff
Teresa M. Petrella, George Dranitsaris, Marc Trudeau, J. Rezmovitz, François Charbonneau, Angie Giotis, Mark Clemons

Bibliographic record

VenueJournal of Clinical Oncology · 2005
Typearticle
Languageen
FieldMedicine
TopicNausea and vomiting management
Canadian institutionsSunnybrook Health Science Centre
Fundersnot available
KeywordsMedicineNauseaAntiemeticVomitingChemotherapyInternal medicineIncidence (geometry)Prospective cohort studyLogistic regressionSurgery

Abstract

fetched live from OpenAlex

8156 Background: Despite modern antiemetic therapy, 20% to 40% of cancer patients receiving chemotherapy fail to achieve complete control of emesis. Several risk factors for acute and delayed nausea/vomiting (n/w) have been identified; these include female gender, daily alcohol intake, chemotherapy emetogenicity and tumour type. Given the many risk factors, it is difficult to subjectively combine them for an overall risk assessment. To address this need we conducted a prospective cohort study to identify risk factors associated with the development of acute and delayed n/w in patients receiving chemotherapy. Methods: Two hundred patients receiving outpatient chemotherapy were asked to complete a questionnaire assessing presence of risk factors prior to their first cycle of chemotherapy. Outcomes were collected using diaries following each cycle of chemotherapy up to 6 cycles. To determine which factors were associated with severe acute and delayed n/w, multivariable logistic regression analysis adjusted for clustering was used. The likelihood ratio test in a backward elimination process was then used to select the final covariates into the model. Risk score categories were calculated along with the area under the receiver operator curve (AUROC). Results: The 200 cancer patients enrolled completed 864 cycles of chemotherapy. Mean age was 58 and 62% were female. The median cycles of chemotherapy completed was 3. Incidence of severe acute n/w was 7.2% (62 of 864 chemo cycles). Incidence of severe delayed n/w was 9.3% (80 of 864 chemo cycles). On multivariate analysis for acute and delayed n/w, 6 factors were identified for acute and 8 for delayed. Based on these regression models, two prediction indices were developed, one for severe acute nausea/vomiting and one for severe delayed nausea/vomiting. AUROC was 0.85 (95%CI: 0.78–0.89) and 0.79(95%CI: 0.74–0.88), respectively. Conclusion: To our knowledge, such indices for prediction of high risk nausea/vomiting are the first in oncology. These tools can be used to identify a priori patients at high risk for nausea/vomiting and allow for optimization of their antiemetic therapy. External validation of the indices is required before wide-spread application. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration GlaxoSmithKline GlaxoSmithKline, Merck

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.008
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.073
GPT teacher head0.424
Teacher spread0.351 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicNausea and vomiting managementFrench-language works237,207